Ask your doctor if this applies even without diabetes. Then ask how it is being measured and how being treated. Or you could read it up yourself here;
Arterial stiffness (25 posts)
Increased arterial stiffness raises stroke risk in type 2 diabetes
Sharif S, et al. Diabet Med. 2019;doi:10.1111/dme.13954.
April 24, 2019
April 24, 2019
Adults
with type 2 diabetes who also have stiffer arteries are more likely to
experience stroke and vascular mortality than those without such
arterial stiffness, according to findings presented in Diabetic Medicine.
“Despite significant advances in both understanding and treatment of type 2 diabetes, people with type 2 diabetes are still at a markedly increased risk of (cardiovascular) mortality and morbidity,” Jan Westerink, MD, PhD, an internist and specialist in the department of vascular medicine at the University Medical Centre Utrecht in the Netherlands, and colleagues wrote. “Part of this increased risk is thought to be explained by increased arterial stiffness, which is more prevalent in people with type 2 diabetes than those without diabetes.”
Westerink and colleagues examined data from 1,910 adults with type 2
diabetes (mean age, 61 years; 30% women) who took part in the Second
Manifestations of Arterial Disease (SMART) study at the University
Medical Centre Utrecht in the Netherlands. The researchers noted that
measures of brachial pulse pressure, ankle-brachial index and carotid
artery distension were used to produce measures of
arterial stiffness.
Participants were followed until March 2015 for an average of 7.5
years, with events of myocardial infarction and stroke as well as
vascular and all-cause mortality logged.
During follow-up, 380 participants experienced a CV event, and there were also 436 deaths reported. Raising brachial pulse pressure by 10 mm Hg increased the likelihood of stroke (HR = 1.17; 95% CI, 1.03-1.32), vascular mortality (HR = 1.14; 95% CI, 1.05-1.23) and a CV event (HR = 1.09; 95% CI, 1.02-1.16) as well as all-cause mortality (HR = 1.1; 95% CI, 1.03-1.16). When excluding participants who were prescribed blood pressure medications, the relationships held for vascular mortality (HR = 1.2; 95% CI, 1.06-1.37), CV events (HR = 1.12; 95% CI, 1-1.26) and all-cause mortality (HR = 1.16; 95% CI, 1.06-1.28).
The researchers also observed that when the ankle-brachial index ratio fell by 0.1 points, participants were at increased risk for vascular mortality (HR = 1.24; 95% CI, 1.06-1.46), a CV event (HR = 1.13; 95% CI, 1.01-1.27) and overall mortality (HR = 1.17; 95% CI, 1.04-1.31), but not when excluding those prescribed BP medications. Similarly, the researchers found that participants were at increased risk for stroke (HR = 1.07; 95% CI, 1-1.15), vascular mortality (HR = 1.04; 95% CI, 1-1.09) and overall mortality (HR = 1.04; 95% CI, 1-1.07) when the carotid artery distensibility coefficient fell 1 U, but the significance did not remain when excluding BP medication users. In addition, while the researchers noted associations between all three measures of arterial stiffness and MI, significance was not reached.
“Despite significant advances in both understanding and treatment of type 2 diabetes, people with type 2 diabetes are still at a markedly increased risk of (cardiovascular) mortality and morbidity,” Jan Westerink, MD, PhD, an internist and specialist in the department of vascular medicine at the University Medical Centre Utrecht in the Netherlands, and colleagues wrote. “Part of this increased risk is thought to be explained by increased arterial stiffness, which is more prevalent in people with type 2 diabetes than those without diabetes.”
During follow-up, 380 participants experienced a CV event, and there were also 436 deaths reported. Raising brachial pulse pressure by 10 mm Hg increased the likelihood of stroke (HR = 1.17; 95% CI, 1.03-1.32), vascular mortality (HR = 1.14; 95% CI, 1.05-1.23) and a CV event (HR = 1.09; 95% CI, 1.02-1.16) as well as all-cause mortality (HR = 1.1; 95% CI, 1.03-1.16). When excluding participants who were prescribed blood pressure medications, the relationships held for vascular mortality (HR = 1.2; 95% CI, 1.06-1.37), CV events (HR = 1.12; 95% CI, 1-1.26) and all-cause mortality (HR = 1.16; 95% CI, 1.06-1.28).
The researchers also observed that when the ankle-brachial index ratio fell by 0.1 points, participants were at increased risk for vascular mortality (HR = 1.24; 95% CI, 1.06-1.46), a CV event (HR = 1.13; 95% CI, 1.01-1.27) and overall mortality (HR = 1.17; 95% CI, 1.04-1.31), but not when excluding those prescribed BP medications. Similarly, the researchers found that participants were at increased risk for stroke (HR = 1.07; 95% CI, 1-1.15), vascular mortality (HR = 1.04; 95% CI, 1-1.09) and overall mortality (HR = 1.04; 95% CI, 1-1.07) when the carotid artery distensibility coefficient fell 1 U, but the significance did not remain when excluding BP medication users. In addition, while the researchers noted associations between all three measures of arterial stiffness and MI, significance was not reached.
No comments:
Post a Comment